MHLW Asks Industry Organization to Take Steps to Ensure Proper COI Management in Response to Diovan Scandal: HPB Director-General at Diet

The scandal regarding the involvement of former employees of Novartis Pharma in investigator-initiated trials (IIT) of the company’s angiotensin receptor blocker (ARB) Diovan (valsartan) was taken up for discussion by the Lower House’s Committee on Health, Labor and Welfare on...read more